Health Catalyst (HCAT) Equity Average (2018 - 2026)

Health Catalyst has reported Equity Average for 9 years, with the latest figure at $192.0 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 48.26% year-over-year to $192.0 million; the trailing twelve-month figure through Mar 2026 stood at $192.0 million (down 48.26% YoY), and the FY2025 full-year result was $305.5 million, down 16.55% from the prior year.
• Equity Average for Q1 2026 stood at $192.0 million, down from $288.9 million in the prior quarter.
• The five-year high for Equity Average was $501.5 million in Q1 2022, with the low at $192.0 million in Q1 2026.
• Historically, Equity Average has averaged $378.0 million across 5 years, with a median of $371.0 million in 2025.
• Annual changes were most pronounced in 2022 — Equity Average soared 84.06% — and 2026, when it plunged 48.26%.
• Health Catalyst's Equity Average stood at $432.5 million in 2022, then fell by 13.37% to $374.7 million in 2023, then declined by 3.88% to $360.1 million in 2024, then dropped by 19.79% to $288.9 million in 2025, then tumbled by 33.54% to $192.0 million in 2026.
• The last three Equity Average figures came in at $192.0 million (Q1 2026), $288.9 million (Q4 2025), and $339.7 million (Q3 2025), per Business Quant data.